432 Results

People

  1. Old
    Old
  2. Wolchok
    Wolchok
  3. Houghton
    Houghton
  4. Gnjatic
    Gnjatic
  5. Allison
    Allison
  6. Ritter
    Ritter
  7. Merghoub
    Merghoub
  8. Jungbluth
    Jungbluth
  9. Yuan
    Yuan
  10. Perales
    Perales

Groups

  1. Department of Medicine (218)
  2. GSK Faculty (208)
  3. Sloan Kettering Institute Faculty (138)
  4. Sloan Kettering Institute Postdocs (132)
  5. Solid Tumor Oncology Division (131)
  6. Hematologic Malignancies, Division of (116)
  7. Center for Hematologic Malignancies (98)
  8. Immunology Program Faculty (97)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (78)
  10. Department of Pathology and Laboratory Medicine (73)
  1. "cd8+ t lymphocyte"
Formats
  1. Journal Article (390)
  2. Review (20)
  3. Editorial (18)
  4. Research Letter (3)
  5. Miscellaneous (1)
Groups
  1. Department of Medicine (218)
  2. GSK Faculty (208)
  3. Sloan Kettering Institute Faculty (138)
  4. Sloan Kettering Institute Postdocs (132)
  5. Solid Tumor Oncology Division (131)
  6. Hematologic Malignancies, Division of (116)

More Groups

People
  1. Jedd Wolchok (55)
  2. Lloyd Old (39)
  3. Alan Houghton (27)
  4. Sacha Gnjatic (26)
  5. Taha Merghoub (26)
  6. Gerd Ritter (23)

More People

Years
  1. 2025 (30)
  2. 2024 (49)
  3. 2023 (35)
  4. 2022 (29)
  5. 2021 (17)
  6. 2020 (22)

More Years

Publications
  1. Blood (23)
  2. Journal of Immunology (21)
  3. Clinical Cancer Research (20)
  4. Nature (19)
  5. PLoS ONE (14)
  6. Proceedings of the National Academy of Sciences of the United States of America (14)

More Publications

Publishers
  1. Nature Publishing Group (73)
  2. American Association for Cancer Research (40)
  3. American Society of Hematology (30)
  4. Elsevier Inc. (29)
  5. Cell Press (27)
  6. The American Association of Immunologists, Inc (21)

More Publishers

Results (432)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
    Journal Article

    Samstein, R. M.; Krishna, C.; Ma, X.; Pei, X.; Lee, K. W.; Makarov, V.; Kuo, F.; Chung, J.; Srivastava, R. M.; Purohit, T. A.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering
    Journal Article

    Arora, A.; Olshen, A. B.; Seshan, V. E.; Shen, R.
    Genome Medicine (2020)

    Fulltext@MSK | Save
  • Clonal expansion of innate and adaptive lymphocytes
    Review

    Adams, N. M.; Grassmann, S.; Sun, J. C.
    Nature Reviews Immunology (2020)

    Fulltext@MSK | Save
  • TGF-β suppresses type 2 immunity to cancer
    Journal Article

    Liu, M.; Kuo, F.; Capistrano, K. J.; Kang, D.; Nixon, B. G.; Shi, W.; Chou, C.; Do, M. H.; Stamatiades, E. G.; Gao, S.; more...
    Nature (2020)

    Fulltext@MSK | Save
  • Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients
    Journal Article

    Machiels, J. P.; Gomez-Roca, C.; Michot, J. M.; Zamarin, D.; Mitchell, T.; Catala, G.; Eberst, L.; Jacob, W.; Jegg, A. M.; Cannarile, M. A.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase Ib trial of personalized neoantigen therapy plus anti-PD-1 in patients with advanced melanoma, non-small cell lung cancer, or bladder cancer
    Journal Article

    Ott, P. A.; Hu-Lieskovan, S.; Chmielowski, B.; Govindan, R.; Naing, A.; Bhardwaj, N.; Margolin, K.; Awad, M. M.; Hellmann, M. D.; Lin, J. J.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • Enhancing mucosal immunity by transient microbiota depletion
    Journal Article

    Becattini, S.; Littmann, E. R.; Seok, R.; Amoretti, L.; Fontana, E.; Wright, R.; Gjonbalaj, M.; Leiner, I. M.; Plitas, G.; Hohl, T. M.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling
    Journal Article

    Antonelli, A. C.; Binyamin, A.; Hohl, T. M.; Glickman, M. S.; Redelman-Sidi, G.
    Proceedings of the National Academy of Sciences of the United States of America (2020)

    Fulltext@MSK | Save
  • HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
    Journal Article

    Hoefflin, R.; Harlander, S.; Schäfer, S.; Metzger, P.; Kuo, F.; Schönenberger, D.; Adlesic, M.; Peighambari, A.; Seidel, P.; Chen, C. Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • DPP8/9 inhibitors activate the CARD8 inflammasome in resting lymphocytes
    Journal Article

    Johnson, D. C.; Okondo, M. C.; Orth, E. L.; Rao, S. D.; Huang, H. C.; Ball, D. P.; Bachovchin, D. A.
    Cell Death & Disease (2020)

    Fulltext@MSK | Save